Cell Therapy News Volume 25.17 | Jun 3 2024

    0
    74








    2024-06-03 | CTN 25.17


    Cell Therapy News by STEMCELL Technologies
    Vol. 25.17 – 3 June, 2024
    TOP STORY

    Claudin18.2-Specific CAR T Cells in Gastrointestinal Cancers: Phase I Trial Final Results

    The authors presented the final results of this single-arm, open-label, Phase I trial, which evaluated the safety and efficacy of satri-cel in patients with CLDN18.2-positive advanced gastrointestinal cancers.
    [Nature Medicine]

    Abstract
    June 2024 Science Events
    PUBLICATIONSRanked by the impact factor of the journal

    Mapping Variant Effects on Anti-Tumor Hallmarks of Primary Human T Cells with Base-Editing Screens

    Researchers performed massively parallel base-editing screens to generate thousands of variants at gene loci annotated with known or potential clinical relevance.
    [Nature Biotechnology]

    Full ArticlePress Release

    The BTLA–HVEM Axis Restricts CAR T Cell Efficacy in Cancer

    Investigators deleted BTLA in CAR T cells and show improved tumor control and persistence in models of lymphoma and solid malignancies.
    [Nature Immunology]

    Abstract

    Gene Therapy for Lafora Disease in the Epm2a-/- Mouse Model

    Scientists used the Epm2a-/- knock-out mouse model of Lafora disease to apply gene therapy by administering intracerebroventricular injections of a recombinant adeno-associated virus carrying the human EPM2A gene.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Mucosal-Associated Invariant T Cells Are Functionally Impaired in Pediatric and Young Adult Patients following Allogeneic Hematopoietic Stem Cell Transplantation and Their Recovery Correlates with Clinical Outcomes

    Investigators retrospectively studied mucosal-associated invariant T cell recovery in 145 consecutive children and young adults with hematological malignancies undergoing allo-hematopoietic stem cell transplant, between April/2019 and May/2022.
    [Haematologica]

    Abstract

    Lentivirus-Mediated Gene Therapy Corrects Ribosomal Biogenesis and Shows Promise for Diamond Blackfan Anemia

    The authors showed that, unlike patients with Fanconi anemia, the hematopoietic stem cell reservoir of patients with Diamond Blackfan anemia (DBA) was not significantly reduced, suggesting that collection of these cells should not constitute a remarkable restriction for DBA gene therapy.
    [JCI Insight]

    Full ArticleGraphical Abstract

    Tissue Specific Stem Cell Therapy for Airway Regeneration

    Researchers developed an animal model that closely mirrored the histopathological changes observed in patients with secondary atrophic rhinitis. Upon administering human nasal turbinate stem cells embedded in collagen type I hydrogel in these models, they observed ciliary regeneration.
    [Cell Proliferation]

    Full Article

    In Silico Study of Heterogeneous Tumor-Derived Organoid Response to CAR T Cell Therapy

    Scientists introduced an agent-based model (ABM), built upon a previous ABM, to rationalize the outcomes of different CAR T-cells therapies strategies over heterogeneous tumour-derived organoids.
    [Scientific Reports]

    Full Article

    Genome-Wide RNA Interference of the Nhr Gene Family in Barber’s Pole Worm Identified Members Crucial for Larval Viability In Vitro

    Investigators curated the nhr gene family for 60 major parasitic nematodes from humans and animals. Compared with the free-living model organism Caenorhabditis elegans, a remarkable contraction of the nhr family was revealed in parasitic species.
    [Infection Genetics and Evolution]

    AbstractGraphical Abstract
    Attend the Translational T Cell Talks on Tuesday, June 11, to hear some of the latest in T cell therapy development.
    REVIEWS

    Chimeric Antigen Receptor T Cell Therapy for Autoimmune Disease

    Scientists highlight important considerations, such as optimal target cell populations, CAR construct design, acceptable toxicities and potential for lasting immune reset, that will inform the eventual safe adoption of CAR T cell therapy for the treatment of autoimmune diseases.
    [Nature Reviews Immunology]

    Abstract

    Bispecific Antibodies and Autologous Chimeric Antigen Receptor T Cell Therapies for Treatment of Hematological Malignancies

    Investigators explored the mechanisms underlying autologous CAR-T therapies and bispecific antibodies, focusing on their clinical application in multiple myeloma, ALL, and non-Hodgkin lymphoma.
    [Molecular Therapy]

    AbstractGraphical Abstract

    Limbal Stem Cell Therapy

    The authors highlight the progress and future direction of limbal stem cell therapies for the treatment of limbal stem cell deficiency, summarizing underlying mechanisms, limitations, and future areas of development.
    [Current Opinion In Ophthalmology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Cincinnati Children’s to Boost Trials Capacity with New Cell Therapy Centre

    Cincinnati Children’s Hospital Medical Center in the US has announced plans to expand its clinical trials capacity by establishing the Applied Gene and Cell Therapy Center.
    [Clinical Trials Arena]

    Press Release

    Now Streaming: Award-Winning Documentary on Penn-Developed Transformative CAR T Cell Cancer Cure

    The award-winning documentary “Of Medicine and Miracles” details the journey of one family alongside a team of Penn Medicine and Children’s Hospital of Philadelphia (CHOP) doctors who developed a revolutionary cancer cure with CAR T cell therapy technology.
    [Penn Medicine]

    Press Release
    FEATURED EVENT

    International Retinoids Conference VII

    July 7 – 11, 2024
    Saint Paul, Minnesota, United States

    > See All Events

    JOB OPPORTUNITIES

    Experience Lead – CAR-T Cell Therapy

    Johnson & Johnson – Palm Beach, Florida, United States

    Scientists – Varied Biology Fields

    Chinese Academy of Sciences – Beijing, China

    Postdoctoral Scholar – Synthetic Extracellular Matrix

    University of Oregon – Eugene, Oregon, United States

    PhD Scholarship – Regulatory T Cell Therapy for Inflammatory Bowel Disease

    Monash University – Melbourne, Victoria, Australia

    MSc/PhD Position – Cell Stress and Inflammation

    University of Manitoba – Winnipeg City, Manitoba, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2